Topical Review: Pediatric Food Allergies Among Diverse Children. View Abstract
Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. View Abstract
Trends in hospitalizations for food-induced anaphylaxis in US children, 2000-2009. View Abstract
Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. View Abstract
Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up. View Abstract
Favorable trends in the frequency of U.S. emergency department visits for food allergy, 2001-2009. View Abstract
An update on self-injectable epinephrine. View Abstract
Longitudinal study of 954 patients with stinging insect anaphylaxis. View Abstract
National survey of pediatric services available in US emergency departments. View Abstract
Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. View Abstract
Predictors of hospital admission for food-related allergic reactions that present to the emergency department. View Abstract
Frequency of US emergency department visits for food-related acute allergic reactions. View Abstract
Age-related differences in the clinical presentation of food-induced anaphylaxis. View Abstract
Season of birth and food-induced anaphylaxis in Boston. View Abstract
Trends in pediatric emergency department visits for food-induced anaphylaxis. View Abstract
Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department. View Abstract
Repeat epinephrine treatments for food-related allergic reactions that present to the emergency department. View Abstract
North-south differences in US emergency department visits for acute allergic reactions. View Abstract
Season of birth and food allergy in children. View Abstract
Multicenter study of repeat epinephrine treatments for food-related anaphylaxis. View Abstract
Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. View Abstract
Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. View Abstract
ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. View Abstract